MENU
Contact

Steven Kasok

Steve Kasok is an operationally oriented financial executive with broad life science expertise. He co-founded and served as CFO of Brammer Bio and Gallus Biopharmaceuticals which are both now part of Thermo Fisher Scientific. He previously served on the Boards of Cognate Bioservices and Brammer Bio. His operational responsibilities have included Finance, Business Development, Human Resources, Information Technology and the Legal functions. Kasok’s broader industry experiences included roles as Vice President and Treasurer of Millipore Corporation, CFO of Cabot Supermetals, and Treasurer and Business Development Officer at Haemonetics Corp, and a variety of roles in GE. He earned a BS in Finance from Clarkson University and an MBA from Harvard Business School.

Daniel Wiegand, MSChE

Daniel is Co-founder, CEO and Board Director of EnPlusOne Bio. Previously, Daniel was an Advanced Technology Team staff member at the Wyss Institute for Biologically Inspired Engineering and Dr. George Church’s lab at Harvard Medical School. At the Wyss, Daniel was extensively involved in developing translational technology revolving around microarray based high throughput DNA/RNA oligonucleotide library synthesis, large scale gene assembly and fluorescence in situ gene sequencing (FISSEQ).

During his tenure at the Wyss Institute, Daniel lead the development of several cell free protein expression systems from non-standard bacteria such as Vibrio natriegens, Streptomyces coelicolor and Pseudomonas aeruginosa. His passion for protein engineering,